• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Citeline adds service for site identification in China

Citeline adds service for site identification in China

January 7, 2015
CenterWatch Staff

Citeline, an Informa business unit, has released Chinatrove, the newest addition to its suite of pharma R&D intelligence services.

Chinatrove is designed to help pharmaceutical companies and CROs streamline their identification of potential sites from among CFDA-certified hospitals. These are the only sites sanctioned for running local clinical trials, a government requirement for anyone aiming to bring a new drug to market in China.

Assuming CFDA approved hospitals have the specific equipment and infrastructure needed for a trial can be a costly oversight. Chinatrove will help companies generate better site target lists by providing key site prequalification information, including key clinical department heads' contact information.

"Well regarded industry experts have shared with Citeline that trial sites in China have failed due to lack of critical medical or laboratory equipment," said Christine Blazynski, Ph.D., senior vice president, new product development. "We sought a solution to help minimize these failures and developed Chinatrove. And, in building this new product, we feel we've added transparency to the clinical trial space around the world's largest population and market."

Knowing which hospitals have the right disease certifications, the appropriate departments with adequate numbers of specialists, hospital level and grade, bed count, outpatient turnover/day and required diagnostic, treatment and laboratory equipment will facilitate decision-making by both the pharma companies and CROs seeking to run trials in China.

"The numbers of public hospitals approved to run clinical trials is growing," said Cydney Brooks, Ph.D., senior director, product management and strategy. "The breadth of diseases receiving CFDA approval also is increasing, as well as penetration beyond the very large city hospitals into smaller hospitals and cities—all of which create potential opportunities for selecting sites."

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing